NDC 0480-2602 – Dextromethorphan hydrobromide and quinidine sulfate

Dextromethorphan Hydrobromide 20 mg/1; Quinidine Sulfate 10 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC0480-2602

Product details

Brand name
Dextromethorphan hydrobromide and quinidine sulfate
Generic name
Dextromethorphan hydrobromide and quinidine sulfate
Labeler
Teva Pharmaceuticals, Inc.
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA202934
Marketed since
September 16, 2026
Listing expires
December 31, 2027
Pharmacologic class
Antiarrhythmic; Cytochrome P450 2D6 Inhibitor; Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Dextromethorphan hydrobromide and quinidine sulfate →

Package NDC codes (1)

Package NDCDescriptionSince
0480-2602-0660 CAPSULE in 1 BOTTLE (0480-2602-06)Sep 16, 2026

Other Dextromethorphan hydrobromide and quinidine sulfate products